1
|
Lin HZ, Qi Z, Wu QM, Jiang YY, Peng JB. Palladium-catalyzed intramolecular asymmetric hydrocyclopropanylation of alkynes: synthesis of cyclopropane-fused γ-lactams. Chem Sci 2023; 14:7564-7568. [PMID: 37449077 PMCID: PMC10337766 DOI: 10.1039/d3sc02168h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Accepted: 06/15/2023] [Indexed: 07/18/2023] Open
Abstract
A palladium-catalyzed intramolecular asymmetric hydrocyclopropanylation of alkynes via C(sp3)-H activation has been developed for the synthesis of cyclopropane-fused γ-lactams. The presented strategy proceeds in a selective and 100% atom-economical manner. A range of cyclopropane-fused γ-lactams were prepared from readily available substrates in good yields and enantioselectivities with a chiral phosphoramidite ligand.
Collapse
Affiliation(s)
- Han-Ze Lin
- School of Biotechnology and Health Sciences, Wuyi University Jiangmen Guangdong 529020 People's Republic of China
| | - Zhuang Qi
- School of Biotechnology and Health Sciences, Wuyi University Jiangmen Guangdong 529020 People's Republic of China
| | - Qi-Min Wu
- School of Biotechnology and Health Sciences, Wuyi University Jiangmen Guangdong 529020 People's Republic of China
| | - Yong-Yu Jiang
- School of Biotechnology and Health Sciences, Wuyi University Jiangmen Guangdong 529020 People's Republic of China
| | - Jin-Bao Peng
- School of Biotechnology and Health Sciences, Wuyi University Jiangmen Guangdong 529020 People's Republic of China
| |
Collapse
|
2
|
Liu J, Han J, Izawa K, Sato T, White S, Meanwell NA, Soloshonok VA. Cyclic tailor-made amino acids in the design of modern pharmaceuticals. Eur J Med Chem 2020; 208:112736. [PMID: 32966895 DOI: 10.1016/j.ejmech.2020.112736] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2020] [Revised: 08/03/2020] [Accepted: 08/04/2020] [Indexed: 12/15/2022]
Abstract
Tailor-made AAs are indispensable components of modern medicinal chemistry and are becoming increasingly prominent in new drugs. In fact, about 30% of small-molecule pharmaceuticals contain residues of tailor-made AAs or structurally related diamines and amino-alcohols. Cyclic tailor-made AAs present a particular value to rational structural design by virtue of their local conformational constraints and are widely used in lead optimization programs. The present review article highlights 34 compounds, all of which are derived from cyclic AAs, representing recently-approved, small-molecule pharmaceuticals as well as promising drug candidates currently in various phases of clinical study. For each compound, the discussion includes the discovery, therapeutic profile and optimized synthesis, with a focus on the preparation of cyclic tailor-made AA as the principal structural feature. The present review article is intended to serve as a reference source for organic, medicinal and process chemists along with other professionals working in the fields of drug design and pharmaceutical discovery.
Collapse
Affiliation(s)
- Jiang Liu
- Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing, 210037, Jiangsu, China
| | - Jianlin Han
- Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing, 210037, Jiangsu, China
| | - Kunisuke Izawa
- Hamari Chemicals Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, 533-0024, Japan.
| | - Tatsunori Sato
- Hamari Chemicals Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, 533-0024, Japan
| | - Sarah White
- Oakwood Chemical, Inc, 730 Columbia Hwy. N, Estill, SC, 29918, USA
| | - Nicholas A Meanwell
- Department of Small Molecule Drug Discovery, Bristol Myers Squibb Research and Early Development, PO Box, 4000, Princeton, NJ, 08543 4000, United States
| | - Vadim A Soloshonok
- Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizábal 3, 20018, San Sebastián, Spain; IKERBASQUE, Basque Foundation for Science, María Díaz de Haro 3, Plaza Bizkaia, 48013, Bilbao, Spain.
| |
Collapse
|
3
|
Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin. Pharmaceutics 2019; 11:pharmaceutics11090452. [PMID: 31480788 PMCID: PMC6781548 DOI: 10.3390/pharmaceutics11090452] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2019] [Revised: 08/11/2019] [Accepted: 08/26/2019] [Indexed: 11/28/2022] Open
Abstract
Drug substance degradation kinetics in solid dosage forms is rarely mechanistically modeled due to several potential micro-environmental and manufacturing related effects that need to be integrated into rate laws. The aim of our work was to construct a model capable of predicting individual degradation product concentrations, taking into account also formulation composition parameters. A comprehensive study was done on active film-coated tablets, manufactured by layering of the drug substance, a primary amine compound saxagliptin, onto inert tablet cores. Formulation variables like polyethylene glycol (PEG) 6000 amount and film-coat polymer composition are incorporated into the model, and are connected to saxagliptin degradation, via formation of reactive impurities. Derived reaction equations are based on mechanisms supported by ab initio calculations of individual reaction activation energies. Alongside temperature, relative humidity, and reactant concentration, the drug substance impurity profile is dependent on micro-environmental pH, altered by formation of acidic PEG degradation products. A consequence of pH lowering, due to formation of formic acid, is lower formation of main saxagliptin degradation product epi-cyclic amidine, a better resistance of formulation to high relative humidity conditions, and satisfactory tablet appearance. Discovered insights enhance the understanding of degradational behavior of similarly composed solid dosage forms on overall drug product quality and may be adopted by pharmaceutical scientists for the design of a stable formulation.
Collapse
|
4
|
Hyde AM, Ashley ER. Organometallic Approaches to [3.1.0] Bicycles in Process Chemistry. TOP ORGANOMETAL CHEM 2019. [DOI: 10.1007/3418_2019_30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
|
6
|
Liu F, ding D, Pan X, Yu W, Li X, Chen S. An Cost-Effective and Safe Process of L-cis-4,5-Methanoproline Amide, the Key Synthetic Intermediate of Saxagliptin, via an Improved Simmons-Smith Reaction. HETEROCYCLES 2015. [DOI: 10.3987/com-14-13164] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
7
|
Nishida Y, Hosokawa N, Murai M, Takai K. Isolation and Structural Characterization of Geminal Di(iodozincio)methane Complexes Stabilized with Nitrogen Ligands. J Am Chem Soc 2014; 137:114-7. [DOI: 10.1021/ja5114535] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Affiliation(s)
- Yusuke Nishida
- Division of Chemistry and Biotechnology, Graduate School of Natural
Science and Technology and ‡Research Center of New Functional Materials for Energy
Production, Storage, and Transport, Okayama University, 3-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan
| | - Naoki Hosokawa
- Division of Chemistry and Biotechnology, Graduate School of Natural
Science and Technology and ‡Research Center of New Functional Materials for Energy
Production, Storage, and Transport, Okayama University, 3-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan
| | - Masahito Murai
- Division of Chemistry and Biotechnology, Graduate School of Natural
Science and Technology and ‡Research Center of New Functional Materials for Energy
Production, Storage, and Transport, Okayama University, 3-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan
| | - Kazuhiko Takai
- Division of Chemistry and Biotechnology, Graduate School of Natural
Science and Technology and ‡Research Center of New Functional Materials for Energy
Production, Storage, and Transport, Okayama University, 3-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan
| |
Collapse
|